BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

244 related articles for article (PubMed ID: 22807679)

  • 1. The receptor Slamf1 on the surface of myeloid lineage cells controls susceptibility to infection by Trypanosoma cruzi.
    Calderón J; Maganto-Garcia E; Punzón C; Carrión J; Terhorst C; Fresno M
    PLoS Pathog; 2012; 8(7):e1002799. PubMed ID: 22807679
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interaction of Signaling Lymphocytic Activation Molecule Family 1 (SLAMF1) receptor with Trypanosoma cruzi is strain-dependent and affects NADPH oxidase expression and activity.
    Poveda C; Herreros-Cabello A; Callejas-Hernández F; Osuna-Pérez J; Maza MC; Chillón-Marinas C; Calderón J; Stamatakis K; Fresno M; Gironès N
    PLoS Negl Trop Dis; 2020 Sep; 14(9):e0008608. PubMed ID: 32925918
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CCL3/Macrophage Inflammatory Protein-1α Is Dually Involved in Parasite Persistence and Induction of a TNF- and IFNγ-Enriched Inflammatory Milieu in
    Gibaldi D; Vilar-Pereira G; Pereira IR; Silva AA; Barrios LC; Ramos IP; Mata Dos Santos HA; Gazzinelli R; Lannes-Vieira J
    Front Immunol; 2020; 11():306. PubMed ID: 32194558
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CD28 is required for T cell activation and IFN-gamma production by CD4+ and CD8+ T cells in response to Trypanosoma cruzi infection.
    Martins GA; Campanelli AP; Silva RB; Tadokoro CE; Russo M; Cunha FQ; Rizzo LV; Silva JS
    Microbes Infect; 2004 Nov; 6(13):1133-44. PubMed ID: 15488732
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Experimental Trypanosoma cruzi infection in platelet-activating factor receptor-deficient mice.
    Talvani A; Santana G; Barcelos LS; Ishii S; Shimizu T; Romanha AJ; Silva JS; Soares MB; Teixeira MM
    Microbes Infect; 2003 Jul; 5(9):789-96. PubMed ID: 12850205
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differential susceptibility to acute Trypanosoma cruzi infection in BALB/c and C57BL/6 mice is not associated with a distinct parasite load but cytokine abnormalities.
    Roggero E; Perez A; Tamae-Kakazu M; Piazzon I; Nepomnaschy I; Wietzerbin J; Serra E; Revelli S; Bottasso O
    Clin Exp Immunol; 2002 Jun; 128(3):421-8. PubMed ID: 12067296
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impaired production of proinflammatory cytokines and host resistance to acute infection with Trypanosoma cruzi in mice lacking functional myeloid differentiation factor 88.
    Campos MA; Closel M; Valente EP; Cardoso JE; Akira S; Alvarez-Leite JI; Ropert C; Gazzinelli RT
    J Immunol; 2004 Feb; 172(3):1711-8. PubMed ID: 14734753
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Challenge of chronically infected mice with homologous trypanosoma cruzi parasites enhances the immune response but does not modify cardiopathy: implications for the design of a therapeutic vaccine.
    Rosas-Jorquera CE; Sardinha LR; Pretel FD; Bombeiro AL; D'Império Lima MR; Alvarez JM
    Clin Vaccine Immunol; 2013 Feb; 20(2):248-54. PubMed ID: 23254299
    [TBL] [Abstract][Full Text] [Related]  

  • 9. During Trypanosoma cruzi infection CD1d-restricted NK T cells limit parasitemia and augment the antibody response to a glycophosphoinositol-modified surface protein.
    Duthie MS; Wleklinski-Lee M; Smith S; Nakayama T; Taniguchi M; Kahn SJ
    Infect Immun; 2002 Jan; 70(1):36-48. PubMed ID: 11748161
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Trypanosoma cruzi carrying a targeted deletion of a Tc52 protein-encoding allele elicits attenuated Chagas' disease in mice.
    Garzón E; Borges MC; Cordeiro-da-Silva A; Nacife V; Meirelles Mde N; Guilvard E; Bosseno MF; Guevara AG; Brenière SF; Ouaissi A
    Immunol Lett; 2003 Oct; 89(1):67-80. PubMed ID: 12946866
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of Trypanosoma cruzi infection on nitric oxide synthase and arginase expression and activity in young and elderly mice.
    Felizardo AA; Caldas IS; Mendonça AAS; Gonçalves RV; Tana FL; Almeida LA; Novaes RD
    Free Radic Biol Med; 2018 Dec; 129():227-236. PubMed ID: 30248443
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Trypanosoma cruzi: roles for perforin-dependent and perforin-independent immune mechanisms in acute resistance.
    Nickell SP; Sharma D
    Exp Parasitol; 2000 Apr; 94(4):207-16. PubMed ID: 10831388
    [TBL] [Abstract][Full Text] [Related]  

  • 13. STING Signaling Drives Production of Innate Cytokines, Generation of CD8
    Vieira RS; Nascimento MS; Noronha IH; Vasconcelos JRC; Benvenuti LA; Barber GN; Câmara NOS; Kalil J; Cunha-Neto E; Almeida RR
    Front Immunol; 2021; 12():775346. PubMed ID: 35095849
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increased susceptibility of Stat4-deficient and enhanced resistance in Stat6-deficient mice to infection with Trypanosoma cruzi.
    Tarleton RL; Grusby MJ; Zhang L
    J Immunol; 2000 Aug; 165(3):1520-5. PubMed ID: 10903759
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Trypanosoma cruzi: IL-10, TNF, IFN-gamma, and IL-12 regulate innate and acquired immunity to infection.
    Abrahamsohn IA; Coffman RL
    Exp Parasitol; 1996 Nov; 84(2):231-44. PubMed ID: 8932773
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antigen-specific Il-4- and IL-10-secreting CD4+ lymphocytes increase in vivo susceptibility to Trypanosoma cruzi infection.
    Barbosa de Oliveira LC; Curotto de Lafaille MA; Collet de Araujo Lima GM; de Almeida Abrahamsohn I
    Cell Immunol; 1996 May; 170(1):41-53. PubMed ID: 8660798
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Trypanosoma cruzi Infection Imparts a Regulatory Program in Dendritic Cells and T Cells via Galectin-1-Dependent Mechanisms.
    Poncini CV; Ilarregui JM; Batalla EI; Engels S; Cerliani JP; Cucher MA; van Kooyk Y; González-Cappa SM; Rabinovich GA
    J Immunol; 2015 Oct; 195(7):3311-24. PubMed ID: 26324777
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pivotal role of interleukin-12 and interferon-gamma axis in controlling tissue parasitism and inflammation in the heart and central nervous system during Trypanosoma cruzi infection.
    Michailowsky V; Silva NM; Rocha CD; Vieira LQ; Lannes-Vieira J; Gazzinelli RT
    Am J Pathol; 2001 Nov; 159(5):1723-33. PubMed ID: 11696433
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibitory receptors are expressed by Trypanosoma cruzi-specific effector T cells and in hearts of subjects with chronic Chagas disease.
    Argüello RJ; Albareda MC; Alvarez MG; Bertocchi G; Armenti AH; Vigliano C; Meckert PC; Tarleton RL; Laucella SA
    PLoS One; 2012; 7(5):e35966. PubMed ID: 22574131
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Contribution of NK, NK T, gamma delta T, and alpha beta T cells to the gamma interferon response required for liver protection against Trypanosoma cruzi.
    Sardinha LR; Elias RM; Mosca T; Bastos KR; Marinho CR; D'Império Lima MR; Alvarez JM
    Infect Immun; 2006 Apr; 74(4):2031-42. PubMed ID: 16552032
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.